Synthesis, molecular Docking and biological evaluation of new 1-Aryl-3-[3-(thieno[3,2-b]pyridin-7-ylthio)phenylureas as Potent Type II VEGFR-2 Tyrosine Kinase inhibitors
The vascular endothelial growth factor receptor 2 (VEGFR-2) is a tyrosine kinase receptor, expressed primarily in endothelial cells, and is activated by the specific binding of VEGF to the VEGFR-2 extracellular regulatory domain. Once activated, VEGFR-2 undergoes autophosphorylation, triggering sign...
Main Author: | |
---|---|
Other Authors: | , , , , , , |
Format: | conferenceObject |
Language: | eng |
Published: |
2015
|
Online Access: | http://hdl.handle.net/10198/12280 |
Country: | Portugal |
Oai: | oai:bibliotecadigital.ipb.pt:10198/12280 |